These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12620667)

  • 1. Inhibition of human serum arylesterase by metal chlorides.
    Debord J; Bollinger JC; Merle L; Dantoine T
    J Inorg Biochem; 2003 Feb; 94(1-2):1-4. PubMed ID: 12620667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new automated method for phenotyping arylesterase (EC 3.1.1.2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate.
    Haagen L; Brock A
    Eur J Clin Chem Clin Biochem; 1992 Jul; 30(7):391-5. PubMed ID: 1525262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities.
    Gan KN; Smolen A; Eckerson HW; La Du BN
    Drug Metab Dispos; 1991; 19(1):100-6. PubMed ID: 1673382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of arylesterase by aliphatic alcohols.
    Debord J; Dantoine T; Bollinger JC; Abraham MH; Verneuil B; Merle L
    Chem Biol Interact; 1998 May; 113(2):105-15. PubMed ID: 9717512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous monitoring of arylesterase in human serum.
    Lorentz K; Wirtz W; Weiss T
    Clin Chim Acta; 2001 Jun; 308(1-2):69-78. PubMed ID: 11412818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular weight and substrate characteristics of human serum arylesterase following purification by immuno-affinity chromatography.
    Tanaka-Kawai H; Yomoda S
    Clin Chim Acta; 1993 Jun; 215(2):127-38. PubMed ID: 8403430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraoxonase and arylesterase activities in stent restenosis in bare metal stent.
    Demirbag R; Sezen Y; Yeşilay AB; Bas M; Yildiz A; Guntekin U; Aksoy N
    Coron Artery Dis; 2011 Aug; 22(5):289-93. PubMed ID: 21394024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The polymorphic paraoxonase/arylesterase isozymes of human serum.
    La Du BN; Eckerson HW
    Fed Proc; 1984 May; 43(8):2338-41. PubMed ID: 6325253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.
    Aviram M; Rosenblat M; Billecke S; Erogul J; Sorenson R; Bisgaier CL; Newton RS; La Du B
    Free Radic Biol Med; 1999 Apr; 26(7-8):892-904. PubMed ID: 10232833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of two rat liver proteins with paraoxonase activity: biochemical evidence for the identity of paraoxonase and arylesterase.
    Rodrigo L; Gil F; Hernández AF; Pla A
    Chem Biol Interact; 1999 May; 119-120():263-75. PubMed ID: 10421461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization, and ligand exchange reactivity of a series of first row divalent metal 3-hydroxyflavonolate complexes.
    Grubel K; Rudzka K; Arif AM; Klotz KL; Halfen JA; Berreau LM
    Inorg Chem; 2010 Jan; 49(1):82-96. PubMed ID: 19954165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase.
    Smolen A; Eckerson HW; Gan KN; Hailat N; La Du BN
    Drug Metab Dispos; 1991; 19(1):107-12. PubMed ID: 1673383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum paraoxonase and arylesterase activities for the evaluation of patients with chronic hepatitis.
    Aslan M; Horoz M; Nazligul Y; Bolukbas C; Bolukbas FF; Selek S; Aksoy N; Erel O
    Int J Clin Pract; 2008 Jul; 62(7):1050-5. PubMed ID: 17887991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia.
    Aslan M; Kosecik M; Horoz M; Selek S; Celik H; Erel O
    Atherosclerosis; 2007 Apr; 191(2):397-402. PubMed ID: 16684543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat inactivation of paraoxonase and arylesterase activities in human and rabbit serum.
    Simeon V; Pavković E
    Chem Biol Interact; 1993 Jun; 87(1-3):103-7. PubMed ID: 8393733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase and arylesterase activities in fibromyalgia.
    Altindag O; Gur A; Calgan N; Soran N; Celik H; Selek S
    Redox Rep; 2007; 12(3):134-8. PubMed ID: 17623520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase and arylesterase activities in children with iron deficiency anemia and vitamin B12 deficiency anemia.
    Koc A; Cengiz M; Ozdemir ZC; Celik H
    Pediatr Hematol Oncol; 2012 May; 29(4):345-53. PubMed ID: 22568797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased paraoxonase and arylesterase activities in the pathogenesis of future atherosclerotic heart disease in women with gestational diabetes mellitus.
    Camuzcuoglu H; Toy H; Cakir H; Celik H; Erel O
    J Womens Health (Larchmt); 2009 Sep; 18(9):1435-9. PubMed ID: 19698032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients.
    Yildiz A; Gur M; Demirbag R; Yilmaz R; Akyol S; Aslan M; Erel O
    Clin Biochem; 2008 Jul; 41(10-11):779-84. PubMed ID: 18355454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraoxonase and arylesterase activities in patients with cardiac syndrome X, and their relationship with oxidative stress markers.
    Gur M; Yildiz A; Demirbag R; Yilmaz R; Aslan M; Ozdogru I; Erel O
    Coron Artery Dis; 2007 Mar; 18(2):89-95. PubMed ID: 17301599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.